Reinfection confirmed by SARS-CoV-2 in a healthcare professional detected by an in-hospital infection control program

doi:10.1016/j.eimce.2022.11.004

Case Reports

. 2023 Jan;41(1):50-51.

doi: 10.1016/j.eimce.2022.11.004. Epub 2022 Nov 22.

Reinfection confirmed by SARS-CoV-2 in a healthcare professional detected by an in-hospital infection control program

Maria Teresa Mestre-Prad¹, Gemma Recio-Comí², M Carmen Molina-Clavero², Maria Montserrat Olona-Cabases³

Affiliations

¹ Unitat Bàsica de Prevenció de Riscos Laborals, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain. Electronic address: mtmestre.hj23.ics@gencat.cat.
² Laboratorio Clínico ICS Camp de Tarragona, Terres de l'Ebre, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
³ Departamento de Epidemiología y Medicina Preventiva, Universitat Rovira i Virgili, Hospital Universitari de Tarragona Joan XXIII, IISPV Instituto de Investigación, Tarragona, Spain.

PMID: 36456432
PMCID: PMC9678830
DOI: 10.1016/j.eimce.2022.11.004

Case Reports

Reinfection confirmed by SARS-CoV-2 in a healthcare professional detected by an in-hospital infection control program

Maria Teresa Mestre-Prad et al. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan.

. 2023 Jan;41(1):50-51.

doi: 10.1016/j.eimce.2022.11.004. Epub 2022 Nov 22.

Authors

Maria Teresa Mestre-Prad¹, Gemma Recio-Comí², M Carmen Molina-Clavero², Maria Montserrat Olona-Cabases³

Affiliations

¹ Unitat Bàsica de Prevenció de Riscos Laborals, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain. Electronic address: mtmestre.hj23.ics@gencat.cat.
² Laboratorio Clínico ICS Camp de Tarragona, Terres de l'Ebre, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
³ Departamento de Epidemiología y Medicina Preventiva, Universitat Rovira i Virgili, Hospital Universitari de Tarragona Joan XXIII, IISPV Instituto de Investigación, Tarragona, Spain.

PMID: 36456432
PMCID: PMC9678830
DOI: 10.1016/j.eimce.2022.11.004

No abstract available

PubMed Disclaimer

Figures

**Figure 1**
Chronology of the onset of symptoms, molecular diagnosis and serological follow-up.

See this image and copyright information in PMC

Cited by

Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers.
Algarate S, Serrano L, Bueno J, Herrero-Cortina B, Alvarado E, González-Barriga MT, Ducons M, Montero-Marco J, Arnal S, Acha B, Riesgo M, Taboada A, Sanz-Burillo P, Yuste C, Benito R, On Behalf Of The Ripovac Study Group. Algarate S, et al. Int J Mol Sci. 2023 Jun 27;24(13):10713. doi: 10.3390/ijms241310713. Int J Mol Sci. 2023. PMID: 37445893 Free PMC article.

References

1. To K.K., Tsang O.T., Leung W.S., Tam A.R., Wu T.C., Lung D.C., et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565. - PMC - PubMed
1. Robbiani D.F., Gaebler C., Muecksch F., Lorenzi J.C.C., Wang Z., Cho A., et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437. - PMC - PubMed
1. Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371 - PMC - PubMed
1. Harvey R.A., Rassen J.A., Kabelac C.A., Turenne W., Leonard S., Klesh R., et al. Association of SARS-CoV-2 seropositive antibody test with risk of future infection. JAMA Intern Med. 2021 - PMC - PubMed
1. Lou B., Li T., Zheng S., Su Y., Li Z., Liu W., et al. Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset. medRxiv [Internet] 2020 [cited 2020 Apr 4];2020.03.23.20041707. Available from: https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] To K.K., Tsang O.T., Leung W.S., Tam A.R., Wu T.C., Lung D.C., et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565. - PMC - PubMed

[2] To K.K., Tsang O.T., Leung W.S., Tam A.R., Wu T.C., Lung D.C., et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565. - PMC - PubMed

[3] Robbiani D.F., Gaebler C., Muecksch F., Lorenzi J.C.C., Wang Z., Cho A., et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437. - PMC - PubMed

[4] Robbiani D.F., Gaebler C., Muecksch F., Lorenzi J.C.C., Wang Z., Cho A., et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437. - PMC - PubMed

[5] Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371 - PMC - PubMed

[6] Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371 - PMC - PubMed

[7] Harvey R.A., Rassen J.A., Kabelac C.A., Turenne W., Leonard S., Klesh R., et al. Association of SARS-CoV-2 seropositive antibody test with risk of future infection. JAMA Intern Med. 2021 - PMC - PubMed

[8] Harvey R.A., Rassen J.A., Kabelac C.A., Turenne W., Leonard S., Klesh R., et al. Association of SARS-CoV-2 seropositive antibody test with risk of future infection. JAMA Intern Med. 2021 - PMC - PubMed

[9] Lou B., Li T., Zheng S., Su Y., Li Z., Liu W., et al. Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset. medRxiv [Internet] 2020 [cited 2020 Apr 4];2020.03.23.20041707. Available from: https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1. - PMC - PubMed

[10] Lou B., Li T., Zheng S., Su Y., Li Z., Liu W., et al. Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset. medRxiv [Internet] 2020 [cited 2020 Apr 4];2020.03.23.20041707. Available from: https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reinfection confirmed by SARS-CoV-2 in a healthcare professional detected by an in-hospital infection control program

Affiliations

Reinfection confirmed by SARS-CoV-2 in a healthcare professional detected by an in-hospital infection control program

Authors

Affiliations

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous